{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:09:55Z","timestamp":1786975795936,"version":"build-2736575974"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:sec id=\"ab-eoi240050-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Selective laser trabeculoplasty (SLT) is becoming the recommended first choice in the treatment of open-angle glaucoma (OAG). However, whether repeat SLT can be recommended regardless of initial response remains controversial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240050-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To assess the potential of OAG and ocular hypertension (OHT) undergoing repeat laser to respond favorably to SLT, termed\n                      <jats:italic>responsiveness to SLT<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240050-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This post hoc analysis of the Laser in Glaucoma and Ocular Hypertension Trial in China (LiGHT China) was conducted from March 2015 to April 2023 in Zhongshan Ophthalmic Center. Of 1376 newly diagnosed OAG and OHT eyes of 771 adults in the original trial, 180 eyes of 105 participants were included in the present study, which underwent initial and repeat SLT as primary treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240050-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Standard SLT was the primary treatment. Repeat SLT was the first choice of treatment escalation regardless of initial response. IOP reduction after SLT and the duration of effect were analyzed. The maximum reduction in IOP within 2 years after initial SLT and repeat SLT was used to identify potential nonresponsiveness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240050-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>IOP reduction 2 months after SLT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240050-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 180 eyes from 105 Chinese participants (mean [SD] age, 45.6 [14.5] years; 58 [55.2%] male and 47 [44.8%] female) underwent repeat SLT. Initial SLT and repeat SLT were both associated with a reduction in IOP (mean, 4.5 mm Hg; 95% CI, 3.9 to 5.1;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001 and mean, 3.3 mm Hg; 95% CI, 2.7 to 3.8;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001, respectively). The mean (SD) IOP after repeat SLT was 15.8 (3.4) mm Hg, similar to 16.0 (4.0) mm Hg after initial SLT (difference, \u22120.4mm Hg; 95% CI, \u22121.0 to 0.3;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.24). Duration of effect after repeat SLT was longer than after initial SLT (1043 days vs 419 days; hazard ratio, 0.38; 95% CI, 0.29 to 0.50;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). IOP reduction after initial SLT was uncorrelated with that after repeat SLT, and 153 eyes (85.0%) responded favorably to SLT at least once. A subset of 27 eyes (15.0%) was identified as potentially nonresponsive and found distinctive with older age (mean [SD], 54.1 [12.5] years vs 44.2 [14.2] years; difference, 10.5 years; 95% CI, 2.9 to 18.1;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.009), higher proportion of female participants (difference, 27.5%; 95% CI, 3.6 to 51.5;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.03), and lower baseline IOP (difference, \u22123.2 mm Hg; 95% CI, \u22125.2 to \u22121.3;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi240050-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>These post hoc analyses showed that most cases of OAG and OHT were highly responsive to SLT and support the consideration of repeat SLT regardless of initial response, while individuals who are nonresponsive to this treatment may have specific features.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.3133","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T14:02:27Z","timestamp":1724335347000},"page":"918","source":"Crossref","is-referenced-by-count":6,"title":["Responsiveness to Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension"],"prefix":"10.1001","volume":"142","author":[{"given":"Yangfan","family":"Yang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezheng","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zidong","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaona","family":"Ye","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tzu","family":"Ping","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Fan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Nathwani","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Jiang","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus","family":"Gazzard","sequence":"additional","affiliation":[{"name":"National Institute for Health and Care Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minbin","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"LiGHT China Trial Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkai","family":"Lin","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulan","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ge","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlan","family":"Ling","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Zhong","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguo","family":"Zuo","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangang","family":"Xu","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiao","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Huang","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuantao","family":"Hao","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Deng","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Ye","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyi","family":"Zhan","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitong","family":"Huang","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhen","family":"Wang","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhi","family":"Xu","sequence":"additional","affiliation":[{"name":"for the LiGHT China Trial Study Group"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10108","key":"eoi240050r1","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma.","volume":"390","author":"Jonas","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"eoi240050r2","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.07.020705","article-title":"National and subnational prevalence and burden of glaucoma in China: a systematic analysis.","volume":"7","author":"Song","year":"2017","journal-title":"J Glob Health"},{"issue":"10180","key":"eoi240050r6","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial.","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"eoi240050r7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ophtha.2022.09.009","article-title":"Laser in glaucoma and ocular hypertension (LiGHT) trial: six-year results of primary selective laser trabeculoplasty versus eye drops for the treatment of glaucoma and ocular hypertension.","volume":"130","author":"Gazzard","year":"2023","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi240050r8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0161-6420(00)00660-6","article-title":"Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes.","volume":"108","author":"Kramer","year":"2001","journal-title":"Ophthalmology"},{"issue":"4","key":"eoi240050r9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ophtha.2019.10.023","article-title":"Efficacy of repeat selective laser trabeculoplasty in medication-naive open-angle glaucoma and ocular hypertension during the LiGHT trial.","volume":"127","author":"Garg","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi240050r10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4103\/0974-9233.134668","article-title":"Repeat selective laser trabeculoplasty can be effective in eyes with initial modest response.","volume":"21","author":"Khouri","year":"2014","journal-title":"Middle East Afr J Ophthalmol"},{"key":"eoi240050r11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ajo.2021.04.020","article-title":"Laser in glaucoma and ocular hypertension trial (LIGHT) in China\u2014a randomized controlled trial: design and baseline characteristics.","volume":"230","author":"Yang","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi240050r12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0008-4182(03)80060-1","article-title":"Canadian perspectives in glaucoma management: setting target intraocular pressure range.","volume":"38","author":"Damji","year":"2003","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"eoi240050r13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ajo.2005.07.044","article-title":"Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease.","volume":"141","author":"Mills","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"eoi240050r14","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration.","volume":"130","author":"The AGIS Investigators","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi240050r15","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1167\/iovs.16-20710","article-title":"Mechanism of action of selective laser trabeculoplasty and predictors of response.","volume":"58","author":"Gulati","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi240050r16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ogla.2023.10.004","article-title":"Optimal performance of selective laser trabeculoplasty: results from the Swedish Optimal SLT Multicenter Randomized Controlled Trial.","volume":"7","author":"Dahlgren","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"issue":"3","key":"eoi240050r17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/IJG.0b013e31817eee0b","article-title":"Repeat selective laser trabeculoplasty.","volume":"18","author":"Hong","year":"2009","journal-title":"J Glaucoma"},{"issue":"5","key":"eoi240050r18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10792-013-9729-3","article-title":"Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma.","volume":"33","author":"Avery","year":"2013","journal-title":"Int Ophthalmol"},{"key":"eoi240050r19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12886-016-0299-9","article-title":"Repeatability of selective laser trabeculoplasty for open-angle glaucoma.","volume":"16","author":"Francis","year":"2016","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"eoi240050r20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/bjophthalmol-2015-307486","article-title":"Repeatability of selective laser trabeculoplasty.","volume":"100","author":"Polat","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"eoi240050r21","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.ophtha.2019.04.012","article-title":"Primary selective laser trabeculoplasty for open-angle glaucoma and ocular hypertension: clinical outcomes, predictors of success, and safety from the Laser in Glaucoma and Ocular Hypertension Trial.","volume":"126","author":"Garg","year":"2019","journal-title":"Ophthalmology"},{"key":"eoi240050r22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajo.2021.06.012","article-title":"Long-term outcomes of selective laser trabeculoplasty for open-angle glaucoma in the Caribbean.","volume":"232","author":"Realini","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"eoi240050r23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ajo.2011.03.005","article-title":"Intraocular pressure, central corneal thickness, and glaucoma in Chinese adults: the liwan eye study.","volume":"152","author":"Wang","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"eoi240050r24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1136\/bjophthalmol-2017-310877","article-title":"Laser in Glaucoma and ocular hypertension (LiGHT) trial. a multicentre, randomised controlled trial: design and methodology.","volume":"102","author":"Gazzard","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"eoi240050r25","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3892\/etm.2015.2959","article-title":"Selective laser trabeculoplasty in treating post-trabeculectomy advanced primary open-angle glaucoma.","volume":"11","author":"Zhang","year":"2016","journal-title":"Exp Ther Med"},{"key":"eoi240050r26","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2153723","article-title":"Intraocular pressure-lowering potential of subthreshold selective laser trabeculoplasty in patients with primary open-angle glaucoma.","volume":"2016","author":"Zhang","year":"2016","journal-title":"J Ophthalmol"},{"issue":"6","key":"eoi240050r27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/bjophthalmol-2021-320128","article-title":"Intraocular pressure and diurnal fluctuation of open-angle glaucoma and ocular hypertension: a baseline report from the LiGHT China trial cohort.","volume":"107","author":"Yang","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"eoi240050r3","unstructured":"American Academy of Ophthalmology. Primary open-angle glaucoma PPP 2020. Accessed July 24, 2024. https:\/\/www.aao.org\/education\/preferred-practice-pattern\/primary-open-angle-glaucoma-ppp"},{"key":"eoi240050r4","unstructured":"National Institute for Health and Care Excellence. Glaucoma: diagnosis and management. Accessed July 24, 2024. https:\/\/www.nice.org.uk\/guidance\/ng81"},{"key":"eoi240050r5","unstructured":"European Glaucoma Society. Terminology and guidelines for glaucoma (5th edition). Accessed July 24, 2024. https:\/\/eugs.org\/educational_materials\/6"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2822693\/jamaophthalmology_yang_2024_oi_240050_1727818425.57061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:17:20Z","timestamp":1729163840000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2822693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.3133","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,1]]}}}